Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2026

Feb 19, 2026

30893_dirs_2026-02-19_9d475859-d5c1-4f3c-a45c-e8cd1f1c6b71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2026-02-17

Reporting Person: Nash Kevin C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-17 Common Stock A 38181.00 $0.00 Acquired 92485.00 Direct
2026-02-17 Common Stock F 16864.00 $24.89 Disposed 75621.00 Direct
2026-02-17 Common Stock F 4306.00 $24.89 Disposed 71315.00 Direct
2026-02-17 Common Stock S 6317.00 $24.9767 Disposed 64998.00 Direct
2026-02-17 Common Stock S 5568.00 $24.9767 Disposed 59430.00 Direct
2026-02-19 Common Stock A 13880.00 $0.00 Acquired 73310.00 Direct

Footnotes

F1: 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.

F2: These shares vest 100% three years from grant award date.